View ValuationCorona 将来の成長Future 基準チェック /06現在、 Coronaの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Consumer Durables 収益成長13.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.お知らせ • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.すべての更新を表示Recent updatesReported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.お知らせ • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.分析記事 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...お知らせ • Dec 17Corona Corporation to Report Q3, 2026 Results on Feb 04, 2026Corona Corporation announced that they will report Q3, 2026 results on Feb 04, 2026分析記事 • Dec 04Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 29th of June. This...Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (117% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 29% to bring the payout ratio under control, which is more than the 14% EPS growth achieved over the last 5 years.Reported Earnings • Oct 31Second quarter 2026 earnings released: EPS: JP¥9.34 (vs JP¥11.30 in 2Q 2025)Second quarter 2026 results: EPS: JP¥9.34 (down from JP¥11.30 in 2Q 2025). Revenue: JP¥21.3b (flat on 2Q 2025). Net income: JP¥273.0m (down 17% from 2Q 2025). Profit margin: 1.3% (down from 1.6% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).分析記事 • Sep 19Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. This makes the dividend yield...分析記事 • Sep 03Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. The dividend yield will be 3.0...お知らせ • Sep 02Corona Corporation to Report Q2, 2026 Results on Oct 30, 2025Corona Corporation announced that they will report Q2, 2026 results on Oct 30, 2025New Risk • Aug 06New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 108% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 108% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.9% net profit margin).Reported Earnings • Jul 31First quarter 2026 earnings released: JP¥18.21 loss per share (vs JP¥6.44 loss in 1Q 2025)First quarter 2026 results: JP¥18.21 loss per share (further deteriorated from JP¥6.44 loss in 1Q 2025). Revenue: JP¥18.9b (flat on 1Q 2025). Net loss: JP¥532.0m (loss widened 183% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.分析記事 • Jul 24Corona's (TSE:5909) Dividend Will Be ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd...分析記事 • Jul 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd of December...Declared Dividend • Jul 09Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 3.0%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (72% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 23% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 27Corona Corporation to Report Q1, 2026 Results on Jul 30, 2025Corona Corporation announced that they will report Q1, 2026 results on Jul 30, 2025Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥37.77 (vs JP¥44.74 in FY 2024)Full year 2025 results: EPS: JP¥37.77 (down from JP¥44.74 in FY 2024). Revenue: JP¥85.2b (up 3.9% from FY 2024). Net income: JP¥1.10b (down 16% from FY 2024). Profit margin: 1.3% (down from 1.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.お知らせ • May 09Corona Corporation, Annual General Meeting, Jun 26, 2025Corona Corporation, Annual General Meeting, Jun 26, 2025.分析記事 • Mar 22Corona (TSE:5909) Has Affirmed Its Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June...お知らせ • Mar 22Corona Corporation to Report Fiscal Year 2025 Results on May 09, 2025Corona Corporation announced that they will report fiscal year 2025 results on May 09, 2025Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).分析記事 • Feb 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 26th of June, with...Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥59.57 (vs JP¥69.50 in 3Q 2024)Third quarter 2025 results: EPS: JP¥59.57 (down from JP¥69.50 in 3Q 2024). Revenue: JP¥29.0b (down 3.8% from 3Q 2024). Net income: JP¥1.74b (down 14% from 3Q 2024). Profit margin: 6.0% (down from 6.7% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.分析記事 • Dec 20Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June. This...お知らせ • Dec 20Corona Corporation to Report Q3, 2025 Results on Feb 04, 2025Corona Corporation announced that they will report Q3, 2025 results on Feb 04, 2025分析記事 • Dec 04Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 26th of June. The...Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 28th March 2025 Payment date: 26th June 2025 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: JP¥11.30 (vs JP¥7.80 in 2Q 2024)Second quarter 2025 results: EPS: JP¥11.30 (up from JP¥7.80 in 2Q 2024). Revenue: JP¥21.3b (up 10.0% from 2Q 2024). Net income: JP¥330.0m (up 45% from 2Q 2024). Profit margin: 1.6% (up from 1.2% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.分析記事 • Sep 24Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...Upcoming Dividend • Sep 20Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 61% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.8%).分析記事 • Aug 29Corona (TSE:5909) Will Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...お知らせ • Aug 28Corona Corporation to Report Q2, 2025 Results on Oct 30, 2024Corona Corporation announced that they will report Q2, 2025 results on Oct 30, 2024分析記事 • Aug 09Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 4th...Reported Earnings • Aug 01First quarter 2025 earnings released: JP¥6.44 loss per share (vs JP¥7.27 loss in 1Q 2024)First quarter 2025 results: JP¥6.44 loss per share (improved from JP¥7.27 loss in 1Q 2024). Revenue: JP¥18.9b (up 5.5% from 1Q 2024). Net loss: JP¥188.0m (loss narrowed 11% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.お知らせ • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.分析記事 • Jul 26Corona (TSE:5909) Has Announced A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...分析記事 • Jul 12Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...Declared Dividend • Jul 11Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control, which is more than the 1.0% EPS growth achieved over the last 5 years.お知らせ • Jun 27Corona Corporation to Report Q1, 2025 Results on Jul 30, 2024Corona Corporation announced that they will report Q1, 2025 results on Jul 30, 2024Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥44.74 (vs JP¥50.81 in FY 2023)Full year 2024 results: EPS: JP¥44.74 (down from JP¥50.81 in FY 2023). Revenue: JP¥82.0b (down 3.9% from FY 2023). Net income: JP¥1.31b (down 12% from FY 2023). Profit margin: 1.6% (down from 1.7% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • May 12Corona Corporation, Annual General Meeting, Jun 25, 2024Corona Corporation, Annual General Meeting, Jun 25, 2024.分析記事 • Mar 25Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 1st of July. This...お知らせ • Mar 23Corona Corporation to Report Fiscal Year 2024 Results on May 10, 2024Corona Corporation announced that they will report fiscal year 2024 results on May 10, 2024Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: JP¥69.50 (vs JP¥65.42 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.50 (up from JP¥65.42 in 3Q 2023). Revenue: JP¥30.1b (up 2.0% from 3Q 2023). Net income: JP¥2.03b (up 6.3% from 3Q 2023). Profit margin: 6.7% (up from 6.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • Feb 02+ 1 more updateCorona Corporation Provides Dividend Guidance for the Full Year Ending March 31, 2024Corona Corporation provided dividend guidance of JPY 14.00 for the full year ending March 31, 2024.お知らせ • Dec 16Corona Corporation to Report Q3, 2024 Results on Feb 02, 2024Corona Corporation announced that they will report Q3, 2024 results on Feb 02, 2024お知らせ • Nov 02Corona Corporation (TSE:5909) announces an Equity Buyback for 80,000 shares, representing 0.27% for ¥75 million.Corona Corporation (TSE:5909) announces an share repurchase program. Under the program the company will repurchase 80,000 shares, representing 0.27% of its issued share capital, for ¥75 million. The purpose of the program is to enable the implementation of a flexible capital policy in response to changes in the business environment. The program is valid till November 16, 2023. As of October 31, 2023, the company had 29,226,249 issued shares (excluding treasury stock) and 116,205 shares in treasury.Buying Opportunity • Oct 04Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be JP¥1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 56%.Upcoming Dividend • Sep 21Upcoming dividend of JP¥14.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.6%).お知らせ • Sep 16Corona Corporation to Report Q2, 2024 Results on Oct 31, 2023Corona Corporation announced that they will report Q2, 2024 results on Oct 31, 2023Reported Earnings • Jul 29First quarter 2024 earnings released: JP¥7.27 loss per share (vs JP¥1.72 loss in 1Q 2023)First quarter 2024 results: JP¥7.27 loss per share (further deteriorated from JP¥1.72 loss in 1Q 2023). Revenue: JP¥17.9b (down 7.5% from 1Q 2023). Net loss: JP¥212.0m (loss widened 324% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • Jun 28Corona Corporation to Report Q1, 2024 Results on Jul 28, 2023Corona Corporation announced that they will report Q1, 2024 results on Jul 28, 2023Reported Earnings • May 12Full year 2023 earnings released: EPS: JP¥50.81 (vs JP¥32.25 in FY 2022)Full year 2023 results: EPS: JP¥50.81 (up from JP¥32.25 in FY 2022). Revenue: JP¥85.3b (up 8.5% from FY 2022). Net income: JP¥1.48b (up 58% from FY 2022). Profit margin: 1.7% (up from 1.2% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.お知らせ • May 11Corona Corporation, Annual General Meeting, Jun 28, 2023Corona Corporation, Annual General Meeting, Jun 28, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per share at 3.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.8%).Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥65.42 (vs JP¥47.58 in 3Q 2022)Third quarter 2023 results: EPS: JP¥65.42 (up from JP¥47.58 in 3Q 2022). Revenue: JP¥29.5b (up 12% from 3Q 2022). Net income: JP¥1.91b (up 38% from 3Q 2022). Profit margin: 6.5% (up from 5.2% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Dec 08Corona Corporation to Report Q3, 2023 Results on Feb 03, 2023Corona Corporation announced that they will report Q3, 2023 results on Feb 03, 2023Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 9 highly experienced directors. No independent directors (9 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 03Second quarter 2023 earnings released: EPS: JP¥15.77 (vs JP¥11.64 in 2Q 2022)Second quarter 2023 results: EPS: JP¥15.77 (up from JP¥11.64 in 2Q 2022). Revenue: JP¥20.6b (up 2.8% from 2Q 2022). Net income: JP¥460.0m (up 36% from 2Q 2022). Profit margin: 2.2% (up from 1.7% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.お知らせ • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.お知らせ • Nov 01Corona Corporation Announces Dividend for the Second Quarter of Fiscal Year Ending March 2023, Payable on December 2, 2022; Announces Dividend Guidance for Year Ending March 2023Corona Corporation announced dividend of JPY 14 per share for the second quarter of fiscal year ending March 2023. Dividend payable date (as planned) is December 2, 2022. For the year the company expects to pay the dividend of JPY 14 per share.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.9%).お知らせ • Sep 01Corona Corporation to Report Q2, 2023 Results on Nov 01, 2022Corona Corporation announced that they will report Q2, 2023 results on Nov 01, 2022Reported Earnings • Jul 31First quarter 2023 earnings released: JP¥1.72 loss per share (vs JP¥4.98 loss in 1Q 2022)First quarter 2023 results: JP¥1.72 loss per share (up from JP¥4.98 loss in 1Q 2022). Revenue: JP¥19.3b (up 6.9% from 1Q 2022). Net loss: JP¥50.0m (loss narrowed 66% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.お知らせ • Jul 29+ 1 more updateCorona Corporation Announces Dividend for the Second Quarter Ended September 30, 2022; Provides Dividend Guidance for the Year Ending December 31, 2022Corona Corporation announced a dividend of ¥14.00 per share for the second quarter ended September 30, 2022, against ¥14.00 per share paid a year ago.For the year ending December 31, 2022, the company expects a dividend of ¥14.00 per share against ¥14.00 per share paid a year ago.お知らせ • Jun 29Corona Corporation to Report Q1, 2023 Results on Jul 29, 2022Corona Corporation announced that they will report Q1, 2023 results on Jul 29, 2022お知らせ • May 12+ 1 more updateCorona Corporation Announces Dividend for the Year Ended March 2022, Payable on June 29, 2022; Provides Dividend Guidance for the Second Quarter of Fiscal Year March 2023 and Year End March 2023Corona Corporation announced dividend of JPY 14.00 per share for the year ended March 2022 as compared to paid dividend of JPY 14.00 per share a year ago. Dividend payable date (as planned) June 29, 2022. For the second quarter of fiscal year March 2023, the company expected dividend to be JPY 14.00 per share.For the year end March 2023, the company expected dividend to be JPY 14.00 per share.Reported Earnings • May 11Full year 2022 earnings released: EPS: JP¥32.25 (vs JP¥21.46 in FY 2021)Full year 2022 results: EPS: JP¥32.25 (up from JP¥21.46 in FY 2021). Revenue: JP¥78.6b (down 4.3% from FY 2021). Net income: JP¥939.0m (up 50% from FY 2021). Profit margin: 1.2% (up from 0.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 6% per year.お知らせ • May 10Corona Corporation, Annual General Meeting, Jun 28, 2022Corona Corporation, Annual General Meeting, Jun 28, 2022.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 8 highly experienced directors. No independent directors (8 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Apr 08Corona Corporation to Report Fiscal Year 2022 Results on May 10, 2022Corona Corporation announced that they will report fiscal year 2022 results on May 10, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥47.58 (down from JP¥52.24 in 3Q 2021). Revenue: JP¥26.4b (down 6.3% from 3Q 2021). Net income: JP¥1.39b (down 9.1% from 3Q 2021). Profit margin: 5.2% (down from 5.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Feb 02+ 1 more updateCorona Corporation Provides Dividend for the third Quarter of Fiscal 2022; Provides Dividend Guidance for the Year Ending March 31, 2022Corona Corporation announced dividend for the third quarter of fiscal 2022. The company announced to pay dividend of JPY 14.00 per share for the third quarter of fiscal 2022 against JPY 14.00 per share paid a year ago.The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 3.0%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.4%).Reported Earnings • Aug 03First quarter 2022 earnings released: JP¥4.98 loss per share (vs JP¥16.20 loss in 1Q 2021)The company reported a decent first quarter result with reduced losses and improved control over expenses, although revenues were weaker. First quarter 2022 results: Revenue: JP¥18.1b (down 12% from 1Q 2021). Net loss: JP¥145.0m (loss narrowed 69% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.Reported Earnings • May 09Full year 2021 earnings released: EPS JP¥21.46 (vs JP¥13.17 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥82.2b (up 4.4% from FY 2020). Net income: JP¥626.0m (up 63% from FY 2020). Profit margin: 0.8% (up from 0.5% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.お知らせ • May 08+ 1 more updateCorona Corporation Announces Year-End Dividend for the Fiscal Year Ending March 31, 2021, Payable on June 28, 2021; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2022Corona Corporation announced year-end dividend of JPY 14.00 per share for the fiscal year ending March 31, 2021 against JPY 14.00 per share paid a year ago. The dividend is payable on June 28, 2021. The company expects to pay dividend of JPY 14.00 per share for the second quarter of fiscal 2022 against JPY 14.00 per share paid a year ago. The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 2.8%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.3%).お知らせ • Mar 04Corona Corporation to Report Fiscal Year 2021 Results on May 07, 2021Corona Corporation announced that they will report fiscal year 2021 results on May 07, 2021Reported Earnings • Feb 03Third quarter 2021 earnings released: EPS JP¥52.24 (vs JP¥51.07 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥28.2b (up 6.3% from 3Q 2020). Net income: JP¥1.52b (up 2.2% from 3Q 2020). Profit margin: 5.4% (down from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 73% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • Dec 05Corona Corporation to Report Q3, 2021 Results on Feb 02, 2021Corona Corporation announced that they will report Q3, 2021 results on Feb 02, 2021お知らせ • Sep 04Corona Corporation to Report Q2, 2021 Results on Oct 30, 2020Corona Corporation announced that they will report Q2, 2021 results on Oct 30, 2020 このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Corona は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TSE:5909 - アナリストの将来予測と過去の財務データ ( )JPY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数3/31/202685,338991-3,376-731N/A12/31/202585,337732N/AN/AN/A9/30/202585,304702-3031,838N/A6/30/202585,257759N/AN/AN/A3/31/202585,2141,103-1,781-423N/A12/31/202483,8191,143N/AN/AN/A9/30/202484,9571,432-141,405N/A6/30/202483,0321,330N/AN/AN/A3/31/202482,0461,306-2,066-210N/A12/31/202383,1791,208N/AN/AN/A9/30/202382,5861,088-1,458197N/A6/30/202383,8911,320N/AN/AN/A3/31/202385,3351,4822,4553,666N/A12/31/202283,5951,678N/AN/AN/A9/30/202280,4591,1552,4913,630N/A6/30/202279,8881,034N/AN/AN/A3/31/202278,6489392,3273,583N/A12/31/202178,633815N/AN/AN/A9/30/202180,4039533,5185,116N/A6/30/202179,799954N/AN/AN/A3/31/202182,1696264,1606,048N/A12/31/202080,125-17N/AN/AN/A9/30/202078,467-502,2344,339N/A6/30/202082,631319N/AN/AN/A3/31/202078,711385-2,07170N/A12/31/201980,996653N/AN/AN/A9/30/201983,9651,166N/A-1,751N/A6/30/201982,0451,111N/AN/AN/A3/31/201983,1951,248N/A55N/A12/31/201882,8871,406N/AN/AN/A9/30/201883,4781,843N/A3,474N/A6/30/201882,4991,949N/AN/AN/A3/31/201882,1152,104N/A5,196N/A12/31/201782,8652,370N/AN/AN/A9/30/201781,9832,246N/A4,239N/A6/30/201781,1112,126N/AN/AN/A3/31/201780,5981,810N/A4,316N/A12/31/201678,8801,705N/AN/AN/A9/30/201676,4021,295N/A3,277N/A6/30/201676,3241,069N/AN/AN/A3/31/201674,042557N/A3,520N/A12/31/201574,728524N/AN/AN/A9/30/201576,016636N/A4,852N/A6/30/201574,537759N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 5909の予測収益成長が 貯蓄率 ( 0.8% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 5909の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 5909の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 5909の収益がJP市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 5909の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 5909の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YConsumer-durables 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 10:46終値2026/05/22 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Corona Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.
お知らせ • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.
Reported Earnings • May 13Full year 2026 earnings released: EPS: JP¥33.90 (vs JP¥37.77 in FY 2025)Full year 2026 results: EPS: JP¥33.90 (down from JP¥37.77 in FY 2025). Revenue: JP¥85.3b (flat on FY 2025). Net income: JP¥991.0m (down 10% from FY 2025). Profit margin: 1.2% (down from 1.3% in FY 2025). Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • May 12Corona Corporation, Annual General Meeting, Jun 24, 2026Corona Corporation, Annual General Meeting, Jun 24, 2026.
お知らせ • May 10Corona Corporation to Report Fiscal Year 2026 Results on May 12, 2026Corona Corporation announced that they will report fiscal year 2026 results on May 12, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 29 June 2026. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 05Third quarter 2026 earnings released: EPS: JP¥60.52 (vs JP¥59.57 in 3Q 2025)Third quarter 2026 results: EPS: JP¥60.52 (up from JP¥59.57 in 3Q 2025). Revenue: JP¥29.0b (flat on 3Q 2025). Net income: JP¥1.77b (up 1.7% from 3Q 2025). Profit margin: 6.1% (up from 6.0% in 3Q 2025). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings.
分析記事 • Dec 18Corona (TSE:5909) Is Paying Out A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 29th of June, with...
お知らせ • Dec 17Corona Corporation to Report Q3, 2026 Results on Feb 04, 2026Corona Corporation announced that they will report Q3, 2026 results on Feb 04, 2026
分析記事 • Dec 04Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 29th of June. This...
Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (117% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 29% to bring the payout ratio under control, which is more than the 14% EPS growth achieved over the last 5 years.
Reported Earnings • Oct 31Second quarter 2026 earnings released: EPS: JP¥9.34 (vs JP¥11.30 in 2Q 2025)Second quarter 2026 results: EPS: JP¥9.34 (down from JP¥11.30 in 2Q 2025). Revenue: JP¥21.3b (flat on 2Q 2025). Net income: JP¥273.0m (down 17% from 2Q 2025). Profit margin: 1.3% (down from 1.6% in 2Q 2025). Over the last 3 years on average, earnings per share has fallen by 16% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 03 December 2025. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.4%).
分析記事 • Sep 19Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. This makes the dividend yield...
分析記事 • Sep 03Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation ( TSE:5909 ) will pay a dividend of ¥14.00 on the 3rd of December. The dividend yield will be 3.0...
お知らせ • Sep 02Corona Corporation to Report Q2, 2026 Results on Oct 30, 2025Corona Corporation announced that they will report Q2, 2026 results on Oct 30, 2025
New Risk • Aug 06New major risk - Dividend sustainabilityThe dividend is not well covered by earnings and cash flows. Payout ratio: 108% The company is paying a dividend despite having no free cash flows. Dividend yield: 2.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk Dividend is not well covered by earnings and cash flows. Payout ratio: 108% Paying a dividend despite having no free cash flows. Minor Risk Profit margins are more than 30% lower than last year (0.9% net profit margin).
Reported Earnings • Jul 31First quarter 2026 earnings released: JP¥18.21 loss per share (vs JP¥6.44 loss in 1Q 2025)First quarter 2026 results: JP¥18.21 loss per share (further deteriorated from JP¥6.44 loss in 1Q 2025). Revenue: JP¥18.9b (flat on 1Q 2025). Net loss: JP¥532.0m (loss widened 183% from 1Q 2025). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings.
分析記事 • Jul 24Corona's (TSE:5909) Dividend Will Be ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd...
分析記事 • Jul 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 3rd of December...
Declared Dividend • Jul 09Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 3.0%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (72% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 23% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 27Corona Corporation to Report Q1, 2026 Results on Jul 30, 2025Corona Corporation announced that they will report Q1, 2026 results on Jul 30, 2025
Reported Earnings • May 10Full year 2025 earnings released: EPS: JP¥37.77 (vs JP¥44.74 in FY 2024)Full year 2025 results: EPS: JP¥37.77 (down from JP¥44.74 in FY 2024). Revenue: JP¥85.2b (up 3.9% from FY 2024). Net income: JP¥1.10b (down 16% from FY 2024). Profit margin: 1.3% (down from 1.6% in FY 2024). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year.
お知らせ • May 09Corona Corporation, Annual General Meeting, Jun 26, 2025Corona Corporation, Annual General Meeting, Jun 26, 2025.
分析記事 • Mar 22Corona (TSE:5909) Has Affirmed Its Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June...
お知らせ • Mar 22Corona Corporation to Report Fiscal Year 2025 Results on May 09, 2025Corona Corporation announced that they will report fiscal year 2025 results on May 09, 2025
Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Payout ratio is a comfortable 72% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.5%).
分析記事 • Feb 10Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 26th of June, with...
Reported Earnings • Feb 06Third quarter 2025 earnings released: EPS: JP¥59.57 (vs JP¥69.50 in 3Q 2024)Third quarter 2025 results: EPS: JP¥59.57 (down from JP¥69.50 in 3Q 2024). Revenue: JP¥29.0b (down 3.8% from 3Q 2024). Net income: JP¥1.74b (down 14% from 3Q 2024). Profit margin: 6.0% (down from 6.7% in 3Q 2024). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 8% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
分析記事 • Dec 20Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 26th of June. This...
お知らせ • Dec 20Corona Corporation to Report Q3, 2025 Results on Feb 04, 2025Corona Corporation announced that they will report Q3, 2025 results on Feb 04, 2025
分析記事 • Dec 04Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 26th of June. The...
Declared Dividend • Dec 04First half dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 28th March 2025 Payment date: 26th June 2025 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is covered by earnings (29% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 4.3% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Nov 01Second quarter 2025 earnings released: EPS: JP¥11.30 (vs JP¥7.80 in 2Q 2024)Second quarter 2025 results: EPS: JP¥11.30 (up from JP¥7.80 in 2Q 2024). Revenue: JP¥21.3b (up 10.0% from 2Q 2024). Net income: JP¥330.0m (up 45% from 2Q 2024). Profit margin: 1.6% (up from 1.2% in 2Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
分析記事 • Sep 24Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...
Upcoming Dividend • Sep 20Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 61% but the company is not cash flow positive. Trailing yield: 2.9%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.8%).
分析記事 • Aug 29Corona (TSE:5909) Will Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...
お知らせ • Aug 28Corona Corporation to Report Q2, 2025 Results on Oct 30, 2024Corona Corporation announced that they will report Q2, 2025 results on Oct 30, 2024
分析記事 • Aug 09Corona (TSE:5909) Is Due To Pay A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 4th...
Reported Earnings • Aug 01First quarter 2025 earnings released: JP¥6.44 loss per share (vs JP¥7.27 loss in 1Q 2024)First quarter 2025 results: JP¥6.44 loss per share (improved from JP¥7.27 loss in 1Q 2024). Revenue: JP¥18.9b (up 5.5% from 1Q 2024). Net loss: JP¥188.0m (loss narrowed 11% from 1Q 2024). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 2% per year, which means it is significantly lagging earnings growth.
お知らせ • Jul 30+ 1 more updateCorona Corporation Provides Consolidated Earnings Guidance for Period Ending September 2024 and for Year Ending March 2025Corona Corporation provided consolidated earnings guidance for period ending September 2024 and for year ending March 2025. For the period, the company expected net sales of JPY 39,200 million, operating loss of JPY 500 million, loss attributable to owners of parent of JPY 300 million, Basic loss per share of JPY 10.28 per basic share. For the year 2025, the company expected net sales of JPY 85,000 million, operating profit of JPY 1,300 million, profit attributable to owners of parent of JPY 1,200 million, Basic earnings per share of JPY 41.10 per basic share.
分析記事 • Jul 26Corona (TSE:5909) Has Announced A Dividend Of ¥14.00The board of Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend on the 4th of December, with...
分析記事 • Jul 12Corona's (TSE:5909) Dividend Will Be ¥14.00Corona Corporation's ( TSE:5909 ) investors are due to receive a payment of ¥14.00 per share on 4th of December. The...
Declared Dividend • Jul 11Final dividend of JP¥14.00 announcedDividend of JP¥14.00 is the same as last year. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 2.9%, which is higher than the industry average of 1.6%. Sustainability & Growth Dividend is not covered by earnings (102% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. The company's earnings per share (EPS) would need to grow by 13% to bring the payout ratio under control, which is more than the 1.0% EPS growth achieved over the last 5 years.
お知らせ • Jun 27Corona Corporation to Report Q1, 2025 Results on Jul 30, 2024Corona Corporation announced that they will report Q1, 2025 results on Jul 30, 2024
Reported Earnings • May 12Full year 2024 earnings released: EPS: JP¥44.74 (vs JP¥50.81 in FY 2023)Full year 2024 results: EPS: JP¥44.74 (down from JP¥50.81 in FY 2023). Revenue: JP¥82.0b (down 3.9% from FY 2023). Net income: JP¥1.31b (down 12% from FY 2023). Profit margin: 1.6% (down from 1.7% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • May 12Corona Corporation, Annual General Meeting, Jun 25, 2024Corona Corporation, Annual General Meeting, Jun 25, 2024.
分析記事 • Mar 25Corona (TSE:5909) Has Announced A Dividend Of ¥14.00Corona Corporation ( TSE:5909 ) has announced that it will pay a dividend of ¥14.00 per share on the 1st of July. This...
お知らせ • Mar 23Corona Corporation to Report Fiscal Year 2024 Results on May 10, 2024Corona Corporation announced that they will report fiscal year 2024 results on May 10, 2024
Upcoming Dividend • Mar 21Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 04Third quarter 2024 earnings released: EPS: JP¥69.50 (vs JP¥65.42 in 3Q 2023)Third quarter 2024 results: EPS: JP¥69.50 (up from JP¥65.42 in 3Q 2023). Revenue: JP¥30.1b (up 2.0% from 3Q 2023). Net income: JP¥2.03b (up 6.3% from 3Q 2023). Profit margin: 6.7% (up from 6.5% in 3Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • Feb 02+ 1 more updateCorona Corporation Provides Dividend Guidance for the Full Year Ending March 31, 2024Corona Corporation provided dividend guidance of JPY 14.00 for the full year ending March 31, 2024.
お知らせ • Dec 16Corona Corporation to Report Q3, 2024 Results on Feb 02, 2024Corona Corporation announced that they will report Q3, 2024 results on Feb 02, 2024
お知らせ • Nov 02Corona Corporation (TSE:5909) announces an Equity Buyback for 80,000 shares, representing 0.27% for ¥75 million.Corona Corporation (TSE:5909) announces an share repurchase program. Under the program the company will repurchase 80,000 shares, representing 0.27% of its issued share capital, for ¥75 million. The purpose of the program is to enable the implementation of a flexible capital policy in response to changes in the business environment. The program is valid till November 16, 2023. As of October 31, 2023, the company had 29,226,249 issued shares (excluding treasury stock) and 116,205 shares in treasury.
Buying Opportunity • Oct 04Now 21% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be JP¥1,149, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has grown by 56%.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥14.00 per share at 3.0% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. Payout ratio is a comfortable 62% and this is well supported by cash flows. Trailing yield: 3.0%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.6%).
お知らせ • Sep 16Corona Corporation to Report Q2, 2024 Results on Oct 31, 2023Corona Corporation announced that they will report Q2, 2024 results on Oct 31, 2023
Reported Earnings • Jul 29First quarter 2024 earnings released: JP¥7.27 loss per share (vs JP¥1.72 loss in 1Q 2023)First quarter 2024 results: JP¥7.27 loss per share (further deteriorated from JP¥1.72 loss in 1Q 2023). Revenue: JP¥17.9b (down 7.5% from 1Q 2023). Net loss: JP¥212.0m (loss widened 324% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 56% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • Jun 28Corona Corporation to Report Q1, 2024 Results on Jul 28, 2023Corona Corporation announced that they will report Q1, 2024 results on Jul 28, 2023
Reported Earnings • May 12Full year 2023 earnings released: EPS: JP¥50.81 (vs JP¥32.25 in FY 2022)Full year 2023 results: EPS: JP¥50.81 (up from JP¥32.25 in FY 2022). Revenue: JP¥85.3b (up 8.5% from FY 2022). Net income: JP¥1.48b (up 58% from FY 2022). Profit margin: 1.7% (up from 1.2% in FY 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
お知らせ • May 11Corona Corporation, Annual General Meeting, Jun 28, 2023Corona Corporation, Annual General Meeting, Jun 28, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per share at 3.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 29 June 2023. Payout ratio is a comfortable 24% and this is well supported by cash flows. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.8%).
Reported Earnings • Feb 04Third quarter 2023 earnings released: EPS: JP¥65.42 (vs JP¥47.58 in 3Q 2022)Third quarter 2023 results: EPS: JP¥65.42 (up from JP¥47.58 in 3Q 2022). Revenue: JP¥29.5b (up 12% from 3Q 2022). Net income: JP¥1.91b (up 38% from 3Q 2022). Profit margin: 6.5% (up from 5.2% in 3Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Dec 08Corona Corporation to Report Q3, 2023 Results on Feb 03, 2023Corona Corporation announced that they will report Q3, 2023 results on Feb 03, 2023
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 9 highly experienced directors. No independent directors (9 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 03Second quarter 2023 earnings released: EPS: JP¥15.77 (vs JP¥11.64 in 2Q 2022)Second quarter 2023 results: EPS: JP¥15.77 (up from JP¥11.64 in 2Q 2022). Revenue: JP¥20.6b (up 2.8% from 2Q 2022). Net income: JP¥460.0m (up 36% from 2Q 2022). Profit margin: 2.2% (up from 1.7% in 2Q 2022). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
お知らせ • Nov 02Corona Corporation Provides Consolidated Earnings Guidance for Year Ending March 2023Corona Corporation provided consolidated earnings guidance for year ending March 2023. For the period, the company expected net sales of JPY 82,700 million, operating profit of JPY 1,200 million, profit attributable to owners of parent of JPY 1,000 million, Basic earnings per share of JPY 34.34 per basic share.
お知らせ • Nov 01Corona Corporation Announces Dividend for the Second Quarter of Fiscal Year Ending March 2023, Payable on December 2, 2022; Announces Dividend Guidance for Year Ending March 2023Corona Corporation announced dividend of JPY 14 per share for the second quarter of fiscal year ending March 2023. Dividend payable date (as planned) is December 2, 2022. For the year the company expects to pay the dividend of JPY 14 per share.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.9%).
お知らせ • Sep 01Corona Corporation to Report Q2, 2023 Results on Nov 01, 2022Corona Corporation announced that they will report Q2, 2023 results on Nov 01, 2022
Reported Earnings • Jul 31First quarter 2023 earnings released: JP¥1.72 loss per share (vs JP¥4.98 loss in 1Q 2022)First quarter 2023 results: JP¥1.72 loss per share (up from JP¥4.98 loss in 1Q 2022). Revenue: JP¥19.3b (up 6.9% from 1Q 2022). Net loss: JP¥50.0m (loss narrowed 66% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 9% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
お知らせ • Jul 29+ 1 more updateCorona Corporation Announces Dividend for the Second Quarter Ended September 30, 2022; Provides Dividend Guidance for the Year Ending December 31, 2022Corona Corporation announced a dividend of ¥14.00 per share for the second quarter ended September 30, 2022, against ¥14.00 per share paid a year ago.For the year ending December 31, 2022, the company expects a dividend of ¥14.00 per share against ¥14.00 per share paid a year ago.
お知らせ • Jun 29Corona Corporation to Report Q1, 2023 Results on Jul 29, 2022Corona Corporation announced that they will report Q1, 2023 results on Jul 29, 2022
お知らせ • May 12+ 1 more updateCorona Corporation Announces Dividend for the Year Ended March 2022, Payable on June 29, 2022; Provides Dividend Guidance for the Second Quarter of Fiscal Year March 2023 and Year End March 2023Corona Corporation announced dividend of JPY 14.00 per share for the year ended March 2022 as compared to paid dividend of JPY 14.00 per share a year ago. Dividend payable date (as planned) June 29, 2022. For the second quarter of fiscal year March 2023, the company expected dividend to be JPY 14.00 per share.For the year end March 2023, the company expected dividend to be JPY 14.00 per share.
Reported Earnings • May 11Full year 2022 earnings released: EPS: JP¥32.25 (vs JP¥21.46 in FY 2021)Full year 2022 results: EPS: JP¥32.25 (up from JP¥21.46 in FY 2021). Revenue: JP¥78.6b (down 4.3% from FY 2021). Net income: JP¥939.0m (up 50% from FY 2021). Profit margin: 1.2% (up from 0.8% in FY 2021). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 6% per year.
お知らせ • May 10Corona Corporation, Annual General Meeting, Jun 28, 2022Corona Corporation, Annual General Meeting, Jun 28, 2022.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 3 experienced directors. 8 highly experienced directors. No independent directors (8 non-independent directors). Vice-President, Executive Officer and Representative Director Kazuyoshi Kobayashi was the last director to join the board, commencing their role in 2015. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Apr 08Corona Corporation to Report Fiscal Year 2022 Results on May 10, 2022Corona Corporation announced that they will report fiscal year 2022 results on May 10, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 28 June 2022. The company is paying out more than 100% of its profits but is generating plenty of cash to support the dividend. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%).
Reported Earnings • Feb 03Third quarter 2022 earnings: Revenues and EPS in line with analyst expectationsThird quarter 2022 results: EPS: JP¥47.58 (down from JP¥52.24 in 3Q 2021). Revenue: JP¥26.4b (down 6.3% from 3Q 2021). Net income: JP¥1.39b (down 9.1% from 3Q 2021). Profit margin: 5.2% (down from 5.4% in 3Q 2021). The decrease in margin was driven by lower revenue. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Feb 02+ 1 more updateCorona Corporation Provides Dividend for the third Quarter of Fiscal 2022; Provides Dividend Guidance for the Year Ending March 31, 2022Corona Corporation announced dividend for the third quarter of fiscal 2022. The company announced to pay dividend of JPY 14.00 per share for the third quarter of fiscal 2022 against JPY 14.00 per share paid a year ago.The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Reported Earnings • Nov 01Second quarter 2022 earnings released: EPS JP¥11.64 (vs JP¥11.63 in 2Q 2021)The company reported a solid second quarter result with improved revenues, although earnings and profit margins were flat. Second quarter 2022 results: Revenue: JP¥20.1b (up 3.1% from 2Q 2021). Net income: JP¥339.0m (flat on 2Q 2021). Profit margin: 1.7% (in line with 2Q 2021). Over the last 3 years on average, earnings per share has fallen by 43% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 29 September 2021. Payment date: 02 December 2021. Trailing yield: 3.0%. Within top quartile of Japanese dividend payers (3.0%). Higher than average of industry peers (1.4%).
Reported Earnings • Aug 03First quarter 2022 earnings released: JP¥4.98 loss per share (vs JP¥16.20 loss in 1Q 2021)The company reported a decent first quarter result with reduced losses and improved control over expenses, although revenues were weaker. First quarter 2022 results: Revenue: JP¥18.1b (down 12% from 1Q 2021). Net loss: JP¥145.0m (loss narrowed 69% from 1Q 2021). Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings.
Reported Earnings • May 09Full year 2021 earnings released: EPS JP¥21.46 (vs JP¥13.17 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥82.2b (up 4.4% from FY 2020). Net income: JP¥626.0m (up 63% from FY 2020). Profit margin: 0.8% (up from 0.5% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 61 percentage points per year, which is a significant difference in performance.
お知らせ • May 08+ 1 more updateCorona Corporation Announces Year-End Dividend for the Fiscal Year Ending March 31, 2021, Payable on June 28, 2021; Provides Dividend Guidance for the Second Quarter and Full Year of Fiscal 2022Corona Corporation announced year-end dividend of JPY 14.00 per share for the fiscal year ending March 31, 2021 against JPY 14.00 per share paid a year ago. The dividend is payable on June 28, 2021. The company expects to pay dividend of JPY 14.00 per share for the second quarter of fiscal 2022 against JPY 14.00 per share paid a year ago. The company expects to pay year-end dividend of JPY 14.00 per share for the fiscal 2022 against JPY 14.00 per share paid a year ago.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥14.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 26 June 2021. Trailing yield: 2.8%. Within top quartile of Japanese dividend payers (2.7%). Higher than average of industry peers (1.3%).
お知らせ • Mar 04Corona Corporation to Report Fiscal Year 2021 Results on May 07, 2021Corona Corporation announced that they will report fiscal year 2021 results on May 07, 2021
Reported Earnings • Feb 03Third quarter 2021 earnings released: EPS JP¥52.24 (vs JP¥51.07 in 3Q 2020)The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: JP¥28.2b (up 6.3% from 3Q 2020). Net income: JP¥1.52b (up 2.2% from 3Q 2020). Profit margin: 5.4% (down from 5.6% in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 73% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • Dec 05Corona Corporation to Report Q3, 2021 Results on Feb 02, 2021Corona Corporation announced that they will report Q3, 2021 results on Feb 02, 2021
お知らせ • Sep 04Corona Corporation to Report Q2, 2021 Results on Oct 30, 2020Corona Corporation announced that they will report Q2, 2021 results on Oct 30, 2020